These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29463533)

  • 1. Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine.
    Armitage EG; Alqaisi AQI; Godzien J; Peña I; Mbekeani AJ; Alonso-Herranz V; López-Gonzálvez Á; Martín J; Gabarro R; Denny PW; Barrett MP; Barbas C
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions.
    Rakotomanga M; Saint-Pierre-Chazalet M; Loiseau PM
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2677-86. PubMed ID: 15980336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes.
    Saint-Pierre-Chazalet M; Ben Brahim M; Le Moyec L; Bories C; Rakotomanga M; Loiseau PM
    J Antimicrob Chemother; 2009 Nov; 64(5):993-1001. PubMed ID: 19749205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of phospholipid species affected by miltefosine action in Leishmania donovani cultures using LC-ELSD, LC-ESI/MS, and multivariate data analysis.
    Imbert L; Ramos RG; Libong D; Abreu S; Loiseau PM; Chaminade P
    Anal Bioanal Chem; 2012 Jan; 402(3):1169-82. PubMed ID: 22065347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani.
    Vacchina P; Norris-Mullins B; Carlson ES; Morales MA
    Parasit Vectors; 2016 Dec; 9(1):621. PubMed ID: 27906059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
    J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanism of miltefosine-mediated death of Leishmania donovani.
    Verma NK; Dey CS
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3010-5. PubMed ID: 15273114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death.
    Mishra J; Singh S
    Exp Parasitol; 2013 Oct; 135(2):397-406. PubMed ID: 23968687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes.
    Rakotomanga M; Blanc S; Gaudin K; Chaminade P; Loiseau PM
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1425-30. PubMed ID: 17242145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Action of Miltefosine on Leishmania donovani Involves the Impairment of Acidocalcisome Function and the Activation of the Sphingosine-Dependent Plasma Membrane Ca
    Pinto-Martinez AK; Rodriguez-Durán J; Serrano-Martin X; Hernandez-Rodriguez V; Benaim G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061745
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India.
    Srivastava S; Mishra J; Gupta AK; Singh A; Shankar P; Singh S
    Parasit Vectors; 2017 Jan; 10(1):49. PubMed ID: 28137296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain.
    Rai K; Cuypers B; Bhattarai NR; Uranw S; Berg M; Ostyn B; Dujardin JC; Rijal S; Vanaerschot M
    mBio; 2013 Oct; 4(5):e00611-13. PubMed ID: 24105765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
    Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
    Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.
    Tiwari B; Pahuja R; Kumar P; Rath SK; Gupta KC; Goyal N
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between the promastigote back-transformation assay and miltefosine treatment outcome.
    Hendrickx S; Eberhardt E; Mondelaers A; Rijal S; Bhattarai NR; Dujardin JC; Delputte P; Cos P; Maes L
    J Antimicrob Chemother; 2015 Nov; 70(11):3023-6. PubMed ID: 26253089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history.
    Reimão JQ; Pita Pedro DP; Coelho AC
    Expert Opin Drug Discov; 2020 Jun; 15(6):647-658. PubMed ID: 32202449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the antileishmanial mechanism of action of the arylimidamide DB766: azole interactions and role of CYP5122A1.
    Pandharkar T; Zhu X; Mathur R; Jiang J; Schmittgen TD; Shaha C; Werbovetz KA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4682-9. PubMed ID: 24890590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis.
    Coelho AC; Trinconi CT; Costa CH; Uliana SR
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e2999. PubMed ID: 25033218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization.
    Shaw CD; Lonchamp J; Downing T; Imamura H; Freeman TM; Cotton JA; Sanders M; Blackburn G; Dujardin JC; Rijal S; Khanal B; Illingworth CJ; Coombs GH; Carter KC
    Mol Microbiol; 2016 Mar; 99(6):1134-48. PubMed ID: 26713880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.
    Deep DK; Singh R; Kulshrestha A; Wajid S; Salotra P
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.